• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Corynebacterium Infections

Corynebacterium Infections - 25 Studies Found

Completed : Evaluation of Boostrix™10 Years After Previous Booster Vaccination
:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria

: 2010-05-20
:
  • Biological: Boostrix™ In

Completed : Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children
: Haemophilus Influenzae Type b (Hib) Infection
: 2010-05-14
:
  • Biological: Monovalent glyco-conjugated vaccine against Haemophilus influenz

Completed : Post Market Surveillance for Infanrix™
:
  • Diphtheria
  • Acellular Pertussis
  • Tetanus

: 2009-05-21
: Biological: GSK Biologicals' Infanrix™ Primary and booster vaccination according to vaccination sc
Completed : Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years
:
  • Tetanus
  • Acellular Pertussis
  • Diphtheria

: 2009-03-26
:
  • Biological: GSK Biologicals'Kinrix®

Completed : Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
:
  • Tetanus
  • Acellular Pertussis
  • Diphtheria

: 2009-02-02
:
  • Biological: Boostrix® Int

Completed : Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children
:
  • Acellular Pertussis
  • Diphtheria
  • Tetanus

: 2008-06-05
:
  • Biological: Infanrix™ In

Completed : Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination
:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria

: 2007-10-22
: Biological: Boostrix™ Intramuscular injection, 1 dose
Terminated : Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.
:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria

: 2007-10-15
:
  • Biological: INFANRIX
  • Biological: BOOSTRIX

Completed : Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
:
  • Acellular Pertussis
  • Tetanus
  • Diphtheria

: 2007-06-21
:
  • Procedure: Taking of blood samples

Completed : Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
:
  • Diphtheria
  • Acellular Pertussis
  • Tetanus

: 2007-03-26
:
  • Biological: Boostrix
  • Biological: Chinese D

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.